Since 2005, PATH Kenya has worked with PEPFAR and USAID to implement the UNAIDS 95-95-95 strategy in nine counties in Western Kenya. By engaging across the health system—from HIV testing service providers, nurses, clinical officers, doctors, as well as county and sub-county management teams—PATH is helping ensure 95% of people living with HIV know their status, 95% are on antiretroviral treatment, and of those, 95% are virally suppressed. PATH supports 121 health facilities with HIV testing and counselling services and in Kisumu County, we support key populations including fisherfolk and truck drivers. PATH is also part of PEPFAR’s DREAMS partnership, which addresses key factors that make adolescent girls and young women vulnerable to HIV. PATH provides financial start-up kits to strengthen girls and young women’s financial independence, reducing their likelihood of contracting HIV or increasing their chances of seeking testing and treatment.

At PATH Kenya, we advocate for strong reproductive, maternal, newborn, child, and adolescent health systems to help women, families, and communities thrive. Our research and development teams focus on policies to scale lifesaving technologies, whether they are vaccines, drugs, diagnostics, or system innovations such as data or digital tools. PATH’s Devices, Diagnostics, and Drugs to Address Women’s Needs (D3AWN) Product Development Partnership is advancing a portfolio of devices, diagnostics, and drugs for preventing and managing postpartum hemorrhage and preeclampsia/eclampsia in African markets. PATH Kenya is collaborating with Kenya’s Ministry of Health, local health management teams, and the University of Nairobi to research how best to integrate the Ellavi uterine balloon tamponade—one of D3AWN’s products—into existing postpartum hemorrhage management programs.

Oxygen is one of the World Health Organization’s 30 essential medicines. It is integral for treating COVID-19, as well as managing other illnesses such as pneumonia, asthma, heart diseases, and severe malaria. Despite this urgent need, there are barriers to accessing medical oxygen in many low and middle-income countries, including Kenya. PATH Kenya is breaking down these barriers to improve access to safe oxygen, during the COVID-19 pandemic and beyond, by assessing respiratory care capacity, analyzing the supplier and market landscape, strengthening distribution strategies, coordinating global respiratory care response, and enabling informed decision-making on product procurement and use.

PATH Kenya has a strong partnership with the Kenya Ministry of Health, collaborating closely to strengthen health systems and optimize policies to support a successful national immunization program and ensure every child is immunized. PATH Kenya is helping introduce the RTS,S malaria vaccine through the malaria vaccine implementation program (MVIP), as well as supporting the ministry of health’s efforts to introduce the typhoid conjugate vaccine and the human papillomavirus vaccine. PATH Kenya also collaborates with the ministry of health to develop vaccine communication strategies and advocacy capacity. The Malaria Vaccine Advocacy Fellowship, for example, is advancing the immunization agenda in Kenya. To increase vaccine coverage, our Living Labs initiative’s human-centered design experts engaged immunization workers to co-design solutions and rapidly test new methods for supporting health workers.

Around the world, millions of children die from preventable illnesses and diseases. By strengthening health systems, advocating for supportive policies, and training health care providers, PATH is working hard to reduce that number. Since 2012, PATH has collaborated with the Kenya Ministry of Health to promote nurturing care for early childhood development (NCfECD) for children under three years of age, building a foundation for lifelong health and well-being. In Siaya County, PATH established an NCfECD multi-sectoral committee that spearheads nurturing care activities and integrates them into existing health systems. Integrated Management of Childhood Illness (IMCI) is a holistic health care approach for children under five. PATH partnered with the Kenya Ministry of Health, the University of Nairobi, and UNITAID to implement IMCI strategies in Kakamega, Kitui, and Uasin Gishu counties. This included training health care workers’ on how to use pulse oximeters and other tools for better diagnosing illnesses and measuring vital signs.